by Yecuris Corporation | Oct 1, 2025 | Press Releases
Seattle BioMed and the Yecuris Corporation today announced that they are to begin testing of novel intervention strategies for malaria, a disease that infects 300 million people a year and claims the lives of up to a million. In partnership with Yecuris, Stefan...
